Dr Reddys Laboratories RDY
NYSE RDY
$12.36 -0.26 (-2.06%)
As of: Oct 1, 2026 · 2:34 PM EDT

Dr Reddys Laboratories (RDY) Long-Term Deferred Tax (2009 - 2026)

Updated

Dr Reddys Laboratories' Long-Term Deferred Tax came in at $244.7 million for the quarter ended Jun 30, 2026, down 13.5% from $282.73 million a year earlier and down 0.3% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Long-Term Deferred Tax (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Dr Reddys Laboratories' Long-Term Deferred Tax was $239 million, up 10.1% from the prior year.

  • Long-Term Deferred Tax has increased in each of the last three years, with a five-year compound annual growth rate of 10.5% (years ended Mar 2021 to Mar 2026).
  • Going back by year, Long-Term Deferred Tax was $217 million in the year ended Mar 31, 2025 (+68.2%), $129 million in the year ended Mar 31, 2024 (+46.6%), $88 million in the year ended Mar 31, 2023 (-18.5%) and $108 million in the year ended Mar 31, 2022 (-25.5%).
  • The five-year range for quarterly Long-Term Deferred Tax is $76.81 million (the quarter ended Dec 31, 2022) to $282.73 million (the quarter ended Jun 30, 2025).
  • Year-over-year, Long-Term Deferred Tax increased in seven of the last eight quarters, with growth averaging 35.5%.
  • The fastest year-over-year change in Long-Term Deferred Tax over five years came in the quarter ended Dec 31, 2023 (growth of 70.7%), and the weakest in the quarter ended Dec 31, 2022 (a decline of 33.3%).
  • Business Quant data shows RDY's Long-Term Deferred Tax at $245.43 million (quarter ended Mar 31, 2026), $238.59 million (quarter ended Dec 31, 2025) and $260.44 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Dr Reddys Laboratories 10.53 Bn 9.72 Bn 396.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 244.70 Mn
Mar 31, 2026 245.43 Mn
Dec 31, 2025 238.59 Mn
Sep 30, 2025 260.44 Mn
Jun 30, 2025 282.73 Mn
Mar 31, 2025 213.73 Mn
Dec 31, 2024 216.42 Mn
Sep 30, 2024 208.64 Mn
Jun 30, 2024 178.64 Mn
Mar 31, 2024 129.74 Mn
Dec 31, 2023 131.11 Mn
Sep 30, 2023 131.07 Mn
Jun 30, 2023 116.17 Mn
Mar 31, 2023 87.54 Mn
Dec 31, 2022 76.81 Mn
Sep 30, 2022 94.81 Mn
Jun 30, 2022 118.49 Mn
Mar 31, 2022 109.11 Mn
Dec 31, 2021 115.15 Mn
Sep 30, 2021 127.16 Mn
API Access

Dr Reddys Laboratories Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=RDY&period=max&api_key=YOUR_API_KEY